CYP2W1
Basic information
Region (hg38): 7:983181-989640
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (112 variants)
- not_provided (5 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP2W1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000017781.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 106 | 113 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 106 | 8 | 3 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYP2W1 | protein_coding | protein_coding | ENST00000308919 | 9 | 6442 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.21e-7 | 0.713 | 125105 | 0 | 67 | 125172 | 0.000268 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.173 | 306 | 315 | 0.973 | 0.0000224 | 3001 |
Missense in Polyphen | 110 | 115.19 | 0.95494 | 1243 | ||
Synonymous | -1.31 | 174 | 153 | 1.13 | 0.0000110 | 1120 |
Loss of Function | 1.24 | 13 | 18.8 | 0.691 | 9.71e-7 | 193 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000267 | 0.000267 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00275 | 0.00272 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000466 | 0.0000443 |
Middle Eastern | 0.00275 | 0.00272 |
South Asian | 0.000100 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Seems to have broad catalytic activity towards several chemicals, including polycyclic aromatic hydrocarbon dihydrodiols and aromatic amines (PubMed:16551781, PubMed:24278521). Active also in the metabolism of indoline substrates and is able to activate aflatoxin B1 into cytotoxic products (PubMed:20805301). Furthermore, it seems to be involved in the oxydation of lysophospholipids and fatty acids (PubMed:22591743). {ECO:0000269|PubMed:16551781, ECO:0000269|PubMed:20805301, ECO:0000269|PubMed:22591743, ECO:0000269|PubMed:24278521}.;
- Pathway
- Oxidation by Cytochrome P450;Metapathway biotransformation Phase I and II;Phase I - Functionalization of compounds;Xenobiotics;Miscellaneous substrates;Cytochrome P450 - arranged by substrate type;Biological oxidations;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.155
Intolerance Scores
- loftool
- 0.526
- rvis_EVS
- 0.53
- rvis_percentile_EVS
- 81.01
Haploinsufficiency Scores
- pHI
- 0.0497
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.510
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.127
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cyp2w1
- Phenotype
Gene ontology
- Biological process
- organic acid metabolic process;xenobiotic metabolic process;exogenous drug catabolic process;aflatoxin B1 metabolic process;oxidation-reduction process
- Cellular component
- cytoplasm;endoplasmic reticulum lumen;endoplasmic reticulum membrane;plasma membrane;cell surface;intracellular membrane-bounded organelle
- Molecular function
- monooxygenase activity;iron ion binding;steroid hydroxylase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;heme binding